Stock profile

GILEAD SCIENCES, INC. (GILD)

GILD · Latest close $150.43 as of Oct 12, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$150.43
As of Oct 12, 2026
Tracked funds holding
3 of 85
2026 Q2 13F filings
Opened / added
0 / 0
vs previous quarter
Trimmed / exited
2
vs previous quarter

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Dodge & Cox Funds1.57%23,677,567TRIMMED (-2.4%)
Ariel Investments0.25%195,657TRIMMED (-3.3%)
Mairs & Power Funds<0.01%2,275HELD

Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end. Fund counts here aggregate every share class mapped to this ticker; research headlines cite filer counts as they stood at publication, so a count here can differ from a headline by a holder (see Methodology, "How holder counts are counted").

All institutions · Form 13F

Institutions holding2,280 of 8,857 filers
Long-only filers among them2,273
Change vs 2026 Q1-10 net · 1,640 entered · 1,650 exited
Shares reported, all filers1,100,538,395
Reported value, all filers$134.8B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryBiological Products, (No Diagnostic Substances) (SIC 2836)
Revenue · FY2025$29.4B
Net income · FY2025$8.5B
Total assets · FY2025$59.0B
Shares outstanding1,239,955,155
Market cap (at latest close)$186.5B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 7, 2026. Shares outstanding as reported Jul 31, 2026.

Short interest

Shares short · Sep 15, 202618,304,875
Share of shares outstanding1.48%
Days to cover3.65

Shares short at recent settlements — Jun 30, 2026: 25.5M · Jul 15, 2026: 25.3M · Jul 31, 2026: 24.4M · Aug 14, 2026: 23.2M · Aug 31, 2026: 23.0M · Sep 15, 2026: 18.3M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 24 sales by 5 insiders ($13.5M).

Source: SEC Form 4 filings, as of Oct 13, 2026. Open-market transactions only.

Politician trading · U.S. Congress

1 member of Congress reported buying (1 purchase vs 0 sales). Bought by Democrats. Latest buy: May 6, 2026.

Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Oct 3, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.

Screens & lenses

Politicians

· Bought by Members — Last 6 months: bought by a member of the U.S. Congress

Financial Screens

· Buffett — Companies with high ROE sustained for more than a decade

· Graham — Sound finances and a long run of profits

· Lynch PEG — Cheap against its growth rate

· Dividend Growth — Dividends raised for more than 10 years

· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%

· Neff Total Return Ratio — Growth plus dividends divided by P/E is high

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Shareholder Yield — Cash returned through dividends and buybacks

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Key figures

· Buffett — Latest ROE: 37.6% · Years ROE ≥15% (of 10): 8 · 10-yr avg ROE: 25.8% · Latest net income: $8.5B

· Graham — Current ratio: 1.55 · Straight profitable years: 19 · Debt ratio: — · Latest net income: $8.5B

· Lynch PEG — P/E: 21.66 · 5-yr EPS growth: 132.4% · PEG: 0.16

· Dividend Growth — Dividend per share: 3.16 · Dividend yield: 2.1% · Straight dividend years: 11 · 10-yr dividend growth: 71.7%

· Cash Flow (FCF) — Latest FCF: $9.5B · FCF yield: 5.1% · Positive FCF years: 3

· Neff Total Return Ratio — EPS growth: 132.4% · Dividend yield: 2.1% · P/E: 21.66 · Neff ratio: 6.21

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 8.38 · Operating cash flow: $10.0B · Net income: $8.5B

· Shareholder Yield — Shareholder yield: 3.2% · of which dividends: 2.2% · of which buybacks: 1.0%

· Bought by Members — Members buying: 1 · Buy txns: 1 · Sell txns: 0 · Latest buy: May 6, 2026

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Politician BEST — appeared in 2 of the last 20 quarterly lists; latest 2025 Q1, ranked #50 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together666.7%+7.5%+0.6%+6.8%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Related stocks

Also held by the tracked funds that hold GILD: MICROSOFT CORP (MSFT) · TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (TSM) · Walt Disney Co (DIS) · BANK OF AMERICA CORP /DE/ (BAC) · JOHNSON & JOHNSON (JNJ) · SCHWAB CHARLES CORP (SCHW) · CHEVRON CORP (CVX) · FISERV INC (FISV) · SLB LIMITED/NV (SLB) · Motorola Solutions, Inc. (MSI).

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.